#$%^&*AU2017204592A120170727.pdf#####Abstract The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients who are likely to be responsive to VEGF 5 antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods. 9241595_1 (GHMatters) P98099.AU.1